1. Home
  2. TAOP vs CDT Comparison

TAOP vs CDT Comparison

Compare TAOP & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAOP
  • CDT
  • Stock Information
  • Founded
  • TAOP 1993
  • CDT 2019
  • Country
  • TAOP China
  • CDT United States
  • Employees
  • TAOP N/A
  • CDT N/A
  • Industry
  • TAOP Computer Software: Prepackaged Software
  • CDT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAOP Technology
  • CDT Health Care
  • Exchange
  • TAOP Nasdaq
  • CDT Nasdaq
  • Market Cap
  • TAOP 4.8M
  • CDT 5.2M
  • IPO Year
  • TAOP N/A
  • CDT N/A
  • Fundamental
  • Price
  • TAOP $3.71
  • CDT $1.57
  • Analyst Decision
  • TAOP
  • CDT
  • Analyst Count
  • TAOP 0
  • CDT 0
  • Target Price
  • TAOP N/A
  • CDT N/A
  • AVG Volume (30 Days)
  • TAOP 26.3K
  • CDT 95.0K
  • Earning Date
  • TAOP 09-04-2025
  • CDT 08-26-2025
  • Dividend Yield
  • TAOP N/A
  • CDT N/A
  • EPS Growth
  • TAOP N/A
  • CDT N/A
  • EPS
  • TAOP N/A
  • CDT N/A
  • Revenue
  • TAOP $36,672,512.00
  • CDT N/A
  • Revenue This Year
  • TAOP N/A
  • CDT N/A
  • Revenue Next Year
  • TAOP N/A
  • CDT N/A
  • P/E Ratio
  • TAOP N/A
  • CDT N/A
  • Revenue Growth
  • TAOP N/A
  • CDT N/A
  • 52 Week Low
  • TAOP $3.52
  • CDT $1.61
  • 52 Week High
  • TAOP $29.40
  • CDT $274.80
  • Technical
  • Relative Strength Index (RSI)
  • TAOP 40.55
  • CDT 30.13
  • Support Level
  • TAOP $3.59
  • CDT $1.61
  • Resistance Level
  • TAOP $3.99
  • CDT $1.85
  • Average True Range (ATR)
  • TAOP 0.38
  • CDT 0.10
  • MACD
  • TAOP 0.03
  • CDT 0.02
  • Stochastic Oscillator
  • TAOP 15.38
  • CDT 13.79

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About CDT Conduit Pharmaceuticals Inc.

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: